Standout Papers

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promi... 2016 2026 2019 2022 723
  1. DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1 (2016)
    Yusuke Ogitani, Tetsuo Aida et al. Clinical Cancer Research

Immediate Impact

2 by Nobel laureates 8 from Science/Nature 60 standout
Sub-graph 1 of 20

Citing Papers

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
5 intermediate papers

Works of Shingo Arakawa being referenced

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
2016 Standout

Author Peers

Author Last Decade Papers Cites
Shingo Arakawa 344 169 720 387 23 1.2k
Kunal S. Taskar 298 225 776 114 30 1.4k
R. Christopher Harmon 431 60 355 145 13 1.1k
Chen Jiang 324 52 400 123 43 930
Michael Tapner 139 183 219 253 27 953
Maurizio Rocchetti 594 122 362 85 35 1.2k
Chaitanya S. Nirodi 593 83 642 79 22 1.3k
Jean–Louis Formento 365 52 833 63 35 1.3k
Selvi Durmuş 468 79 557 64 24 994
Hudie Wei 774 42 517 146 31 1.3k
T Noguchi 355 61 242 204 32 1.1k

All Works

Loading papers...

Rankless by CCL
2026